Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Capacity-Building Assistance To Improve the Delivery and Effectiveness of Human Immunodeficiency Virus Prevention Services for Racial/Ethnic Minority Populations, Program Announcement Number 04019

---
identifier: "/us/fr/04-1168"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Capacity-Building Assistance To Improve the Delivery and Effectiveness of Human Immunodeficiency Virus Prevention Services for Racial/Ethnic Minority Populations, Program Announcement Number 04019"
title_number: 0
title_name: "Federal Register"
section_number: "04-1168"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Capacity-Building Assistance To Improve the Delivery and Effectiveness of Human Immunodeficiency Virus Prevention Services for Racial/Ethnic Minority Populations, Program Announcement Number 04019"
positive_law: false
currency: "2004-01-21"
last_updated: "2004-01-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "04-1168"
document_type: "notice"
publication_date: "2004-01-21"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "69 FR 2936"
fr_volume: 69
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Capacity-Building Assistance To Improve the Delivery and Effectiveness of Human Immunodeficiency Virus Prevention Services for Racial/Ethnic Minority Populations, Program Announcement Number 04019

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Capacity-Building Assistance to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus Prevention Services for Racial/Ethnic Minority Populations, Program Announcement Number 04019.

*Times and Dates:*

1 p.m.-6 p.m., February 8, 2004 (Open)

9 a.m.-5 p.m., February 9, 2004 (Closed)

9 a.m.-5 p.m., February 10, 2004 (Closed)

9 a.m.-5 p.m., February 11, 2004 (Closed)

9 a.m.-5 p.m., February 12, 2004 (Closed)

9 a.m.-5 p.m., February 13, 2004 (Closed)

*Place:* The Wyndhan Atlanta—Downtown, 160 Spring Street, Atlanta, GA 30380, (404) 688-8600.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement Number 04019.

*For Further Information Contact:* Beth Wolfe, Resource Funding Analyst, National Center for HIV, STD, and TB Prevention, CDC, 1600 Clifton Road, NE, MS-E07, Atlanta, GA 30333, Telephone (404) 639-8531.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: January 13, 2004.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).